Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Patients push back against Novo Nordisk move to scrap an insulin product
Reuters
Tuesday, July 30, 2024 - 6:37pm
tags:
Novo Nordisk, diabetes, insulin, Levemir, long-acting insulin, patients
Merck mystified by sudden 'step down' in Gardasil sales in China
Fierce Pharma
Tuesday, July 30, 2024 - 6:36pm
tags:
Merck, Gardasil, China
Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents
Fierce Pharma
Tuesday, July 30, 2024 - 6:35pm
tags:
Sarepta Therapeutics, Sanofi, legal, patents, Elevidys, DMD
Merck (MRK) Q2 Earnings and Revenues Top Estimates
Yahoo/Zacks.com
Tuesday, July 30, 2024 - 6:33pm
tags:
Merck, earnings
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
CNBC
Tuesday, July 30, 2024 - 11:55am
tags:
Pfizer, earnings
Pfizer takes $230M hit after axing failed DMD gene therapy—and tosses out RSV combo vaccine
Fierce Biotech
Tuesday, July 30, 2024 - 11:50am
tags:
Pfizer, DMD, gene therapy, RSV
Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial
BioSpace
Tuesday, July 30, 2024 - 11:48am
tags:
Novo Nordisk, liraglutide, clinical trials, Alzheimer's disease
FDA’s Diversity Action Plan may set a new paradigm for trial transparency
Cl
Tuesday, July 30, 2024 - 11:46am
tags:
FDA, regulatory, clinical trials, clinical trial diversity
Incyte drops pair of PD-L1 drugs as part of 2nd pipeline clear-out this year
Fierce Biotech
Tuesday, July 30, 2024 - 11:44am
tags:
Incyte, anti-PD-L1
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tuesday, July 30, 2024 - 11:41am
tags:
BioNTech, Regeneron, Merck, Moderna Therapeutics, mRNA-4157/V940, melanoma
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics: Study
BioSpace
Tuesday, July 30, 2024 - 11:40am
tags:
Novo Nordisk, Ozempic, smoking cessation, GLP-1 agonists
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tuesday, July 30, 2024 - 11:37am
tags:
Eisai, EMA, Europe, Leqembi, Biogen, Alzheimer's disease
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease
BioSpace
Tuesday, July 30, 2024 - 11:34am
tags:
Ventyx Biosciences, VTX958, Crohn's Disease
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tuesday, July 30, 2024 - 11:30am
tags:
Sanofi, Regeneron, Dupixent
Imunon Reports Promising Phase 2 Ovarian Cancer Trial Results
Tip Ranks
Tuesday, July 30, 2024 - 11:28am
tags:
Imunon, clinical trials, IMNN-001, ovarian cancer
VC dollars pour into biopharma, with Q2 haul signaling sunshine ahead
Fierce Biotech
Monday, July 29, 2024 - 10:48pm
tags:
venture capital, funding
With multi-state agreement worth $86M, Indivior moves to resolve more opioid litigation
Fierce Pharma
Monday, July 29, 2024 - 10:47pm
tags:
Indivior, Suboxone, opioids, opioid crisis, legal
Natera touts positive results for Merkel cell carcinoma surveillance test
Clinical Trials Arena
Monday, July 29, 2024 - 10:45pm
tags:
Natera, diagnostics, Medtech, Merkel cell carcinoma
RSV vaccine makers vying for market share in second year of shots
Reuters
Monday, July 29, 2024 - 10:44pm
tags:
Pfizer, GSK, Moderna Therapeutics, RSV, vaccines
How BioIVT used AI to reimagine art masterpieces for gene therapy awareness
Medical Marketing and Media
Monday, July 29, 2024 - 10:40pm
tags:
BioIVT. gene therapy, artificial intelligence

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.